Pay in 4 interest-free payments of $5.00 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Preliminary data from this early-stage study point to a differentiating clinical profile for ECC5004, highlighting its good tolerability alongside its promising performance in terms of glucose and weight reductions, according to AstraZenecas announcement
GIP-overexpressing mice demonstrate reduced diet-induced obesity and steatosis, and improved glucose homeostasis
Foundayo (Orforglipron) Foundayo, approved in April 2026, is the latest addition to the GLP-1 weight loss market
Priced at 46,000 per 10mg vial at Peptides Costa Rica, every batch is supplied in lyophilized form, independently lab tested, and shipped with a Certificate of Analysis
US$ 27.27
US$ 21.93
US$ 28.38
US$ 25.29
US$ 28.91
US$ 22.74
US$ 28.82
US$ 28.36
